Santen Pharmaceutical Co (JP:4536) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Santen Pharmaceutical Co. has successfully repurchased over 2.2 million of its common shares, amounting to nearly 3.94 billion yen, as part of its ongoing share buyback program. This strategic move aligns with their broader plan to repurchase up to 21.11 million shares by November 6, 2024, reflecting a commitment to enhancing shareholder value.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
